Pharmigene Inc Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Pharmigene Inc

Watchlist Manager

Watchlist

Price: 7.4 TWD

Market Cap: NT$373.5m

P	Pharmigene Inc TPEX:7595	TW
	Pembangunan Jaya Ancol Tbk PT IDX:PJAA	ID
W	WebComm Technology Co Ltd TPEX:6865	TW
	Sono Group NV NASDAQ:SSM	DE
A	ACRO Biomedical Co Ltd TPEX:6748	TW
	Alpha Compute Corp NASDAQ:ALP	VG
	Materialise NV XBRU:MTLS	BE
	Towa Pharmaceutical Co Ltd TSE:4553	JP
R	RMA Global Ltd ASX:RMY	AU
H	Honyi Precision Industry Co Ltd TPEX:4530	TW

Profitability Summary

Pharmigene Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

28%

Sustainable 3Y Average Gross Margin

32%

Declining Gross Margin

36% > 28%

Negative Operating Margin

-24%

Negative 3Y Average Operating Margin

-46%

Operating Margin is Increasing

-37% > -24%

Negative Net Margin

-28%

Negative 3Y Average Net Margin

-52%

Net Margin is Increasing

-37% > -28%

Negative Free Cash Flow Margin

-3%

Negative 3Y Average Free Cash Flow Margin

-145%

Free Cash Flow Margin is Increasing

-515% > -3%

Negative ROE

-18%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-8%

ROIC is Increasing

-10% > -5%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.